Related Experiment Video
Updated: Jun 11, 2025
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.8K
[Novel therapies for MDS and future prospects]
1Department of Hemato-Oncology, Saitama Medical University International Medical Center.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 2, 2024
Summary
Myelodysplastic syndromes (MDS) management is evolving, shifting towards genetic mutations for diagnosis and treatment. New therapies targeting inflammation and specific molecules offer future hope for patients.
Area of Science:
- Hematology
- Oncology
- Genetics
Context:
- Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell diseases.
- Current treatments for higher-risk MDS include allogeneic transplantation and hypomethylating agents (HMAs).
- MDS classification and treatment strategies are rapidly evolving.
Purpose:
- To provide an overview of recent advancements in myelodysplastic syndromes (MDS).
- To highlight the shift in diagnostic classification from morphology to genetic alterations.
- To discuss emerging therapeutic strategies and research directions in MDS.
Summary:
- MDS diagnosis increasingly relies on genetic mutations, influencing international treatment strategies.
- Revised International Working Group (IWG) criteria enhance treatment response assessment.
- Research is exploring the role of inflammation in lower-risk MDS and developing targeted therapies.
Impact:
- The integration of genetic data into MDS classification and treatment is transforming patient care.
- New agents like luspatercept offer improved anemia management.
- Ongoing research into novel molecular targets promises more personalized and effective MDS therapies.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K